Oncology & Cancer

Immunotherapy for brain metastases: Where are we now?

Brain metastases are the most common type of brain tumors, affecting nearly 200,000 people in the United States each year. Once diagnosed, patients have a median survival of sic months. Immunotherapy, a type of cancer treatment ...

Medical research

Mitochondria could boost immunotherapy effectiveness

Boosting mitochondrial function in a subpopulation of T cells could make cancer immunotherapy more effective, according to a recent study published in the Proceedings of the National Academy of Sciences (PNAS).

Oncology & Cancer

A leap forward in research on CAR T cell therapy

In cancer immunotherapy, cells in the patient's own immune system are activated to attack cancer cells. CAR T cell therapy has been one of the most significant recent advances in immunotherapies targeted at cancer.

Immunology

Study may explain the microbiome-immunotherapy connection

Cancer immunotherapy may get a boost from an unexpected direction: bacteria residing within tumor cells. In a new study published in Nature, researchers at the Weizmann Institute of Science and their collaborators have discovered ...

Oncology & Cancer

Cancer immunotherapy approach targets common genetic alteration

Researchers developed a prototype for a new cancer immunotherapy that uses engineered T cells to target a genetic alteration common among all cancers. The approach, which stimulates an immune response against cells that are ...

page 1 from 32